<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NNR</journal-id>
<journal-id journal-id-type="hwp">spnnr</journal-id>
<journal-id journal-id-type="nlm-ta">Neurorehabil Neural Repair</journal-id>
<journal-title>Neurorehabilitation and Neural Repair</journal-title>
<issn pub-type="ppub">1545-9683</issn>
<issn pub-type="epub">1552-6844</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1545968312471901</article-id>
<article-id pub-id-type="publisher-id">10.1177_1545968312471901</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of High-Frequency Repetitive Transcranial Magnetic Stimulation on Motor and Gait Improvement in Incomplete Spinal Cord Injury Patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kumru</surname><given-names>Hatice</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1545968312471901">1</xref>
<xref ref-type="aff" rid="aff2-1545968312471901">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Benito</surname><given-names>Jesus</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1545968312471901">1</xref>
<xref ref-type="aff" rid="aff2-1545968312471901">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Murillo</surname><given-names>Narda</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1545968312471901">1</xref>
<xref ref-type="aff" rid="aff2-1545968312471901">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Valls-Sole</surname><given-names>Josep</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff3-1545968312471901">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Valles</surname><given-names>Margarita</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1545968312471901">1</xref>
<xref ref-type="aff" rid="aff2-1545968312471901">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lopez-Blazquez</surname><given-names>Raquel</given-names></name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff1-1545968312471901">1</xref>
<xref ref-type="aff" rid="aff2-1545968312471901">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Costa</surname><given-names>Ursula</given-names></name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff1-1545968312471901">1</xref>
<xref ref-type="aff" rid="aff2-1545968312471901">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tormos</surname><given-names>Josep M.</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1545968312471901">1</xref>
<xref ref-type="aff" rid="aff2-1545968312471901">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pascual-Leone</surname><given-names>Alvaro</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-1545968312471901">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Vidal</surname><given-names>Joan</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1545968312471901">1</xref>
<xref ref-type="aff" rid="aff2-1545968312471901">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1545968312471901"><label>1</label>Institut Guttmann, Institut Universitari de Neurorehabilitació adscrit a la UAB, Barcelona, Spain</aff>
<aff id="aff2-1545968312471901"><label>2</label>University Autonoma de Barcelona, Barcelona, Spain</aff>
<aff id="aff3-1545968312471901"><label>3</label>Institut d’Investigació Biomèdica August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain</aff>
<aff id="aff4-1545968312471901"><label>4</label>Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA</aff>
<author-notes>
<corresp id="corresp1-1545968312471901">Hatice Kumru, MD, PhD, Hospital de Neurorehabilitació Institut Guttmann, Camí Can Ruti s/n. Barcelona 08916, Barcelona, Spain. Email: <email>hkumru@guttmann.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2013</year>
</pub-date>
<volume>27</volume>
<issue>5</issue>
<fpage>421</fpage>
<lpage>429</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">American Society of Neurorehabilitation</copyright-holder>
</permissions>
<abstract>
<p><italic>Objective</italic>. Incomplete spinal cord injury (SCI) patients have the potential to regain some ambulatory function, and optimal reorganization of remaining circuits can contribute to this recovery. We hypothesized that repetitive transcranial magnetic stimulation (rTMS) may promote active recovery of motor function during gait rehabilitation. <italic>Methods</italic>. A total of 17 incomplete SCI patients were randomized to receive active rTMS or sham stimulation coupled with rehabilitation therapy; 3 patients who began in the sham group crossed over to the active rTMS group after a washout period of more than 3 weeks. Active rTMS consisted of 15 daily sessions over the leg motor area (at 20 Hz). We compared lower-extremity motor score (LEMS), 10-m walking test for walking speed, timed up and go, Walking Index for SCI Scale, Modified Ashworth Scale, and Spinal Cord Injury Spasticity Evaluation Tool at baseline, after the last session, and 2 weeks later in the active rTMS and sham stimulation groups. <italic>Results</italic>. A significant improvement was observed after the last rTMS session in the active group for LEMS, walking speed, and spasticity. Improvement in walking speed was maintained during the follow-up period. Sham stimulation did not induce any improvement in LEMS, gait assessment, and spasticity after the last session and neither during follow-up. <italic>Conclusion</italic>. In incomplete SCI, 15 daily sessions of high-frequency rTMS can improve motor score, walking speed, and spasticity in the lower limbs. The study provides evidence for the therapeutic potential of rTMS in the lower extremities in SCI rehabilitation.</p>
</abstract>
<kwd-group>
<kwd>incomplete SCI</kwd>
<kwd>functional improvement</kwd>
<kwd>transcranial magnetic stimulation</kwd>
<kwd>rehabilitation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1545968312471901" sec-type="intro">
<title>Introduction</title>
<p>The spinal networks involved in locomotion require input from supraspinal structures for adequate control of gait in humans.<sup><xref ref-type="bibr" rid="bibr1-1545968312471901">1</xref></sup> Only those with motor-incomplete spinal cord injury (SCI) demonstrate improvement in their ability to walk overground following gait training, suggesting that supraspinal centers play a critically important role in the recovery of overground locomotor function.<sup><xref ref-type="bibr" rid="bibr2-1545968312471901">2</xref><xref ref-type="bibr" rid="bibr3-1545968312471901"/>-<xref ref-type="bibr" rid="bibr4-1545968312471901">4</xref></sup> Walking function is highly related to motor-evoked potential (MEP) recovery in the tibialis anterior muscle (TA) in SCI patients.<sup><xref ref-type="bibr" rid="bibr5-1545968312471901">5</xref></sup> Thomas and Gorassini<sup><xref ref-type="bibr" rid="bibr6-1545968312471901">6</xref></sup> reported that the degree of locomotor recovery after intensive locomotor training correlated positively with the percentage increase of MEP in the TA or vastus lateralis muscle. With functional magnetic resonance imaging, Winchester et al<sup><xref ref-type="bibr" rid="bibr2-1545968312471901">2</xref></sup> found an increase in activity of the leg motor area after improving gait in persons with SCI.</p>
<p>Spasticity is classically defined as a motor disorder<sup><xref ref-type="bibr" rid="bibr7-1545968312471901">7</xref></sup> that contributes to impairment of voluntary movements in SCI.<sup><xref ref-type="bibr" rid="bibr8-1545968312471901">8</xref></sup> Improvement in spasticity might induce some improvement in motor strength in the lower extremity.<sup><xref ref-type="bibr" rid="bibr9-1545968312471901">9</xref></sup></p>
<p>Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive and painless procedure to modulate cortical excitability of motor areas and induce changes over the descending corticospinal output.<sup><xref ref-type="bibr" rid="bibr10-1545968312471901">10</xref><xref ref-type="bibr" rid="bibr11-1545968312471901"/>-<xref ref-type="bibr" rid="bibr12-1545968312471901">12</xref></sup> This modulation may be useful to promote active recovery of motor function and to obtain functional benefit from gait rehabilitation. Through the use of repetitive high-frequency rTMS, improvement has been reported in motor and sensory functions measured by the American Spinal Cord Injury Association (ASIA) Impairment Scale (AIS) and time to complete a peg-board task in 4 chronic incomplete cervical SCI patients.<sup><xref ref-type="bibr" rid="bibr10-1545968312471901">10</xref></sup></p>
<p>Here we hypothesized that high-frequency rTMS coupled with gait training can improve motor recovery in the lower extremities and locomotion in incomplete SCI patients to a greater degree than sham stimulation.</p>
</sec>
<sec id="section2-1545968312471901" sec-type="methods">
<title>Methods</title>
<p>The study was a randomized, double-blind, sham-controlled trial. We recruited 17 patients with SCI (see details in the following) to be randomly distributed in 2 study groups: an active rTMS group and a sham group. Three patients who began in the sham group were crossed over to the active rTMS group after a washout period of more than 3 weeks. Therefore, 10 individuals were studied in each group. All patients underwent 15 consecutive daily sessions (3 weeks) of active or sham rTMS. Patients and investigators were blinded to the treatment arm except for HK, who applied rTMS.</p>
<sec id="section3-1545968312471901">
<title>Patients</title>
<p>Inclusion criteria were the following: (1) incomplete SCI AIS-D,<sup><xref ref-type="bibr" rid="bibr13-1545968312471901">13</xref></sup> with possible gait capacity; (2) cervical or thoracic SCI; (3) time lapse since SCI between 3 and 12 months; (4) no changes in medical treatment at least 1 week before and during the study; (5) no limitation of passive range of movement in joints; and (6) written informed consent for the study, which was approved by the institutional review board of Institut Guttmann. All patients were naive to rTMS and unaware of the purpose of the study.</p>
<p>A total of 33 individuals were identified as potential participants for this study, and 17 gave informed consent and participated in the study (<xref ref-type="fig" rid="fig1-1545968312471901">Figure 1</xref>). All patients received standard care for SCI rehabilitation at our institution. The program comprises 5 hours of therapy 5 days per week, including training in activities of daily living, occupational therapy for the upper extremities for patients with cervical SCI, fitness training, sports, hydrotherapy, and gait training.</p>
<fig id="fig1-1545968312471901" position="float">
<label>Figure 1.</label>
<caption>
<p>Flow diagram of patient categorizations. Abbreviations: SCI, spinal cord injury; rTMS, repetitive transcranial magnetic stimulation.</p>
</caption>
<graphic xlink:href="10.1177_1545968312471901-fig1.tif"/></fig>
<p>Patients received daily gait training therapy (5 d/wk) during the 3 weeks of rTMS session and for 2 more weeks during follow-up. Each training session lasted 1 hour and consisted of overground gait training assisted by a therapist using orthesis and technical aids as needed, in accordance with the functional level of each patient. The session of overground gait training was performed immediately (within less than 30 minutes) after active or sham rTMS sessions for all patients.</p>
</sec>
<sec id="section4-1545968312471901">
<title>Clinical and Functional Assessment</title>
<p>Primary outcome measurements included the following: (1) lower-extremity motor score (LEMS), obtained from the standardized AIS clinical exam<sup><xref ref-type="bibr" rid="bibr14-1545968312471901">14</xref></sup>; (2) 10-m walking test (=time in seconds to walk 10 m) for walking speed<sup><xref ref-type="bibr" rid="bibr15-1545968312471901">15</xref></sup> (patients were asked to walk at their fastest but most comfortable speed); (3) timed up and go (TUG) test<sup><xref ref-type="bibr" rid="bibr16-1545968312471901">16</xref></sup>; and (4) Walking Index for SCI Scale (WISCI-II; to quantify walking ability).<sup><xref ref-type="bibr" rid="bibr17-1545968312471901">17</xref></sup></p>
<p>Secondary outcome measures included the following: (1) Modified Ashworth Scale (MAS) evaluated at both knees for spasticity assessment<sup><xref ref-type="bibr" rid="bibr18-1545968312471901">18</xref></sup> and (2) the Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET).<sup><xref ref-type="bibr" rid="bibr19-1545968312471901">19</xref></sup></p>
</sec>
<sec id="section5-1545968312471901">
<title>rTMS Protocol</title>
<p>Patients received 15 rTMS sessions, 5 d/wk for 3 weeks, in the morning between 9:00 and noon. We used a MagStim Super Rapid magnetic stimulator (MagStim Company, Whitland, Wales, UK) equipped with a commercially available double-cone coil (each wing measuring 110 mm in diameter), which was held over the vertex. All active and sham rTMS sessions were conducted at rest, with the patient lying supine.</p>
<p>For active (real) rTMS, we applied 2-s long bursts at 20 Hz (40 pulses/burst) with intertrain intervals of 28 s, for a total of 1800 pulses over 20 minutes. These rTMS parameters were selected for this study because when we used it in patients with incomplete SCI for spasticity, some of our patients reported better gait function (data not reported in the article).<sup><xref ref-type="bibr" rid="bibr20-1545968312471901">20</xref></sup> Also, according to previous publications, the magnitude and duration of the after-rTMS effects seem to depend on the total number of stimuli, with longer periods of rTMS inducing a more consistent and persistent change in corticospinal excitability.<sup><xref ref-type="bibr" rid="bibr11-1545968312471901">11</xref>,<xref ref-type="bibr" rid="bibr21-1545968312471901">21</xref>,<xref ref-type="bibr" rid="bibr22-1545968312471901">22</xref></sup></p>
<p>Electromyographic recordings (EMGs) were obtained with pairs of Ag-AgCl surface EMG electrodes placed over the first dorsal interosseous, abductor pollicis brevis, and biceps brachii muscles. We also recorded motor threshold at rest (RMT) in TA on both sides. The intensity of repetitive TMS was set at 90% RMT of the upper-extremity muscles.</p>
<p>For motor threshold determination, the double-cone coil was held lateral to the vertex over the optimal scalp position overlying the contralateral hemisphere to the less-affected side from SCI, from which single-pulse TMS evoked responses of maximum amplitude in muscles in the upper extremity. The EMG signal was amplified (×50) with filters set as 10 to 2000 Hz. RMT was defined as the lowest intensity that elicited MEPs of &gt;50 µV peak-to-peak amplitude in at least 5 of 10 consecutive stimulations.</p>
<p>For sham stimulation, the double-cone coil was held over the vertex but was disconnected from the main stimulator unit. Instead, a second coil (8-shaped) was connected with the MagStim stimulator and discharged under the patient’s pillow. Thus, no current was induced in the brain, and although the patients did not experience a tapping sensation on the scalp, they were exposed to a similar clicking noise. When explicitly asked at the end of the trial, 8 of the 10 patients in the sham stimulation group thought that they had received active stimulation; 2 patients were not sure whether it was active or sham stimulation.</p>
</sec>
<sec id="section6-1545968312471901">
<title>Experimental Design</title>
<p>The experimental protocol included the following steps:</p>
<list id="list1-1545968312471901" list-type="order">
<list-item><p>Clinical and functional assessment at baseline</p></list-item>
<list-item><p>After the first rTMS session, spasticity reevaluation by MAS</p></list-item>
<list-item><p>Daily rTMS sessions for 14 additional days</p></list-item>
<list-item><p>Clinical and functional assessment after completion of the 15th rTMS session</p></list-item>
<list-item><p>Follow-up of functional outcomes (gait) 2 weeks after the last session of rTMS and spasticity reevaluation by SCI-SET.</p></list-item>
</list>
</sec>
<sec id="section7-1545968312471901">
<title>Data Analysis</title>
<p>MAS was calculated for both knees and the results averaged. Data are presented as mean ± standard deviation. Change scores were calculated by subtracting baseline data from the last session of rTMS data and from follow-up period data.</p>
<p>Because the distribution of the data was not normal according to the Kolmogorov-Smirnov test, the Friedman test was used for multiple repeated-measures comparisons and the Wilcoxon <italic>t</italic> for post hoc comparisons. The Mann Whitney <italic>U</italic> test and χ<sup>2</sup> test were used to compare data between different groups of patients. The significance level was set as <italic>P</italic> &lt; .01, with Bonferroni correction for multiple comparisons.</p>
<p>Spearman ρ was used to study correlations between the absolute value of MAS or of SCI-SET and LEMS or gait function and between the change scores in LEMS, SCI-SET, and gait functions. The significance level was set as <italic>P</italic> &lt; .05.</p>
</sec>
</sec>
<sec id="section8-1545968312471901" sec-type="results">
<title>Results</title>
<p>Demographic and clinical characteristics of the patients included in the study are summarized in <xref ref-type="table" rid="table1-1545968312471901">Table 1</xref>. Both groups were homogeneous for age, gender, time lapse since injury, etiology, AIS scale, and LEMS for active and sham groups (<xref ref-type="table" rid="table1-1545968312471901">Table 1</xref> and <xref ref-type="fig" rid="fig2-1545968312471901">Figure 2</xref>). The mean age of patients in the active rTMS group was 32.9 ± 15.4 years and 36.5 ± 13.9 years in the sham rTMS group. The mean time lapse since injury was 8.3 ± 3.1 months in the active rTMS group and 6.8 ± 3.4 months in the sham rTMS group.</p>
<table-wrap id="table1-1545968312471901" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical and Demographic Characteristics of Patients.</p>
</caption>
<graphic alternate-form-of="table1-1545968312471901" xlink:href="10.1177_1545968312471901-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">rTMS</th>
<th align="center">Sex</th>
<th align="center">Age, y</th>
<th align="center">Neurological Lesion Level</th>
<th align="center">AIS</th>
<th align="center">Time Since SCI, mo</th>
<th align="center">Etiology</th>
<th align="center">Pharmacological Treatment</th>
</tr>
</thead>
<tbody>
<tr>
<td>Active</td>
<td>M</td>
<td>29</td>
<td>T12</td>
<td>D</td>
<td>8</td>
<td>Trauma</td>
<td>Baclofen, gabapentin</td>
</tr>
<tr>
<td>Active<sup><xref ref-type="table-fn" rid="table-fn2-1545968312471901">a</xref></sup></td>
<td>M</td>
<td>19</td>
<td>T1</td>
<td>D</td>
<td>6</td>
<td>Tumor</td>
<td>Baclofen, fluoxetina</td>
</tr>
<tr>
<td>Active</td>
<td>M</td>
<td>47</td>
<td>C6</td>
<td>D</td>
<td>8</td>
<td>Trauma</td>
<td>Baclofen</td>
</tr>
<tr>
<td>Active</td>
<td>M</td>
<td>21</td>
<td>C5</td>
<td>D</td>
<td>9</td>
<td>Trauma</td>
<td>Baclofen</td>
</tr>
<tr>
<td>Active</td>
<td>F</td>
<td>51</td>
<td>T7</td>
<td>D</td>
<td>12</td>
<td>Tumor</td>
<td>Clonazepam</td>
</tr>
<tr>
<td>Active</td>
<td>M</td>
<td>60</td>
<td>T7</td>
<td>D</td>
<td>3</td>
<td>Infection</td>
<td>Baclofen</td>
</tr>
<tr>
<td>Active<sup><xref ref-type="table-fn" rid="table-fn2-1545968312471901">a</xref></sup></td>
<td>M</td>
<td>19</td>
<td>T5</td>
<td>D</td>
<td>12</td>
<td>Myelitis</td>
<td>Baclofen, fluoxetina</td>
</tr>
<tr>
<td>Active<sup><xref ref-type="table-fn" rid="table-fn2-1545968312471901">a</xref></sup></td>
<td>M</td>
<td>24</td>
<td>C6</td>
<td>D</td>
<td>5</td>
<td>Trauma</td>
<td>Baclofen</td>
</tr>
<tr>
<td>Active</td>
<td>F</td>
<td>40</td>
<td>C4</td>
<td>D</td>
<td>8</td>
<td>Trauma</td>
<td>Baclofen, venlafaxina, tizanidina</td>
</tr>
<tr>
<td>Active</td>
<td>M</td>
<td>21</td>
<td>T2</td>
<td>D</td>
<td>12</td>
<td>Trauma</td>
<td>Baclofen</td>
</tr>
<tr>
<td>Sham<sup><xref ref-type="table-fn" rid="table-fn2-1545968312471901">a</xref></sup></td>
<td>M</td>
<td>18</td>
<td>T1</td>
<td>D</td>
<td>4</td>
<td>Tumor</td>
<td>Baclofen, fluoxetina</td>
</tr>
<tr>
<td>Sham</td>
<td>M</td>
<td>50</td>
<td>C4</td>
<td>D</td>
<td>5</td>
<td>Trauma</td>
<td>Gabapentin, clonazepam, venlafaxina</td>
</tr>
<tr>
<td>Sham<sup><xref ref-type="table-fn" rid="table-fn2-1545968312471901">a</xref></sup></td>
<td>M</td>
<td>18</td>
<td>T5</td>
<td>D</td>
<td>9</td>
<td>Myelitis</td>
<td>Baclofen, fluoxetina</td>
</tr>
<tr>
<td>Sham</td>
<td>M</td>
<td>56</td>
<td>C6</td>
<td>D</td>
<td>10</td>
<td>Trauma</td>
<td>Baclofen</td>
</tr>
<tr>
<td>Sham</td>
<td>M</td>
<td>34</td>
<td>T7</td>
<td>D</td>
<td>11</td>
<td>Infection</td>
<td>Baclofen</td>
</tr>
<tr>
<td>Sham</td>
<td>M</td>
<td>37</td>
<td>T3</td>
<td>D</td>
<td>12</td>
<td>Trauma</td>
<td>Sirdalud, baclofen</td>
</tr>
<tr>
<td>Sham<sup><xref ref-type="table-fn" rid="table-fn2-1545968312471901">a</xref></sup></td>
<td>M</td>
<td>24</td>
<td>C6</td>
<td>D</td>
<td>3</td>
<td>Trauma</td>
<td>Baclofen</td>
</tr>
<tr>
<td>Sham</td>
<td>F</td>
<td>41</td>
<td>T2</td>
<td>D</td>
<td>5</td>
<td>Infection</td>
<td>Diazepam, gabapentin, mirtazapina</td>
</tr>
<tr>
<td>Sham</td>
<td>M</td>
<td>54</td>
<td>T3</td>
<td>D</td>
<td>3</td>
<td>Infection</td>
<td>Lorazepam</td>
</tr>
<tr>
<td>Sham</td>
<td>F</td>
<td>33</td>
<td>C5</td>
<td>D</td>
<td>6</td>
<td>Tumor</td>
<td align="center">—</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1545968312471901">
<p>Abbreviations: rTMS, repetitive transcranial magnetic stimulation; M, male; F, female; C, cervical; T, thoracic; AIS, American Spinal Cord Injury Association (ASIA) Impairment Scale.</p>
</fn>
<fn id="table-fn2-1545968312471901">
<label>a</label>
<p>Three patients who received sham stimulation first and then received active stimulation after at least a 3-week washout period.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-1545968312471901" position="float">
<label>Figure 2.</label>
<caption>
<p>Total motor score in the lower extremities at baseline and after the last rTMS session for each studied patients (small black circle) and the average of the each group (big black circle). Abbreviations: LEMS, lower-extremity motor score; rTMS, repetitive transcranial magnetic stimulation.</p>
</caption>
<graphic xlink:href="10.1177_1545968312471901-fig2.tif"/></fig>
<p>At baseline, MEPs could be obtained in the TA in only 5 patients, 3 assigned to the active rTMS group (with an RMT of 60%, 48%, and 80%) and 2 assigned to the sham rTMS group (with an RMT of 48% and 86%). In all other patients, we were unable to elicit MEPs in the TA even at 100% TMS intensity. The motor threshold in the TA did not change after 15 days of rTMS sessions in both groups. The mean rTMS intensity used for active rTMS was 39.8% ± 5.8% of maximum stimulator output.</p>
<sec id="section9-1545968312471901">
<title>Adverse Effects</title>
<p>All patients tolerated the study without complications, and no adverse effects were reported, with the exception of 6 patients who complained of a slight twitching of facial muscles during the first session of active stimulation.</p>
</sec>
<sec id="section10-1545968312471901">
<title>Between-Group Comparisons</title>
<p>Absolute mean values at baseline for LEMS, walking speed, TUG, and WISCI-II were similar in both sham and active rTMS groups (Mann-Whitney <italic>U</italic> test, <italic>P</italic> &gt; .2 for all comparisons). At baseline, patients included in the sham group had a significantly lower MAS score than those included in the active rTMS group (Mann-Whitney <italic>U, P</italic> = .04). There were no between-group differences in SCI-SET (Mann-Whitney <italic>U, P</italic> = .39). There were no differences between the active and sham rTMS groups at the end of the last session of rTMS and during follow-up in LEMS and gait scales, MAS, and SCI-SET (Mann-Whitney <italic>U</italic> test, <italic>P</italic> &gt; .1 for each comparison).</p>
<p>Change scores revealed significant improvement in LEMS and in spasticity measured by MAS after 3 weeks of active rTMS in comparison to sham rTMS (<xref ref-type="table" rid="table2-1545968312471901">Table 2</xref>). Improvement in gait parameters was larger in the active rTMS group than in the sham group, but the change scores reached no significant level, neither after the last session of rTMS nor during the follow-up period (<xref ref-type="table" rid="table2-1545968312471901">Table 2</xref>).</p>
<table-wrap id="table2-1545968312471901" position="float">
<label>Table 2.</label>
<caption>
<p>Change Scores for Spasticity and Functional and Clinical Assessment After First and Last Session of rTMS and During the 2-Week Follow-up Period in Active and Sham rTMS.<sup><xref ref-type="table-fn" rid="table-fn4-1545968312471901">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table2-1545968312471901" xlink:href="10.1177_1545968312471901-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="2">First Session<hr/></th>
<th/>
<th align="center" colspan="2">Last Session<hr/></th>
<th/>
<th align="center" colspan="2">Follow-up<hr/></th>
<th/>
</tr>
<tr>
<th/>
<th align="center">Active</th>
<th align="center">Sham</th>
<th align="center"><italic>P</italic></th>
<th align="center">Active</th>
<th align="center">Sham</th>
<th align="center"><italic>P</italic></th>
<th align="center">Active</th>
<th align="center">Sham</th>
<th align="center"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td>LEMS</td>
<td align="center">—</td>
<td align="center">—</td>
<td/>
<td>4.80 (2.78)</td>
<td>1.30 (3.09)</td>
<td>.006</td>
<td>NA</td>
<td>NA</td>
<td/>
</tr>
<tr>
<td>Walking speed</td>
<td align="center">—</td>
<td align="center">—</td>
<td/>
<td>0.16 (0.20)</td>
<td>0.08 (0.21)</td>
<td>.20</td>
<td>0.25 (0.24)</td>
<td>0.14 (0.24)</td>
<td>.14</td>
</tr>
<tr>
<td>TUG</td>
<td align="center">—</td>
<td align="center">—</td>
<td/>
<td>−26.0 (20.17)</td>
<td>−16.0 (19.01)</td>
<td>.40</td>
<td>−35.1 (26.76)</td>
<td>−17.2 (26.82)</td>
<td>.43</td>
</tr>
<tr>
<td>WISCI-II</td>
<td align="center">—</td>
<td align="center">—</td>
<td/>
<td>1.6 (2.41)</td>
<td>2.0 (2.56)</td>
<td>.93</td>
<td>1.5 (2.32)</td>
<td>3.0 (2.47)</td>
<td>.54</td>
</tr>
<tr>
<td>MAS</td>
<td>−0.68(0.35)</td>
<td>0.18 (0.2)</td>
<td>&lt;.0001</td>
<td>−0.70 (0.55)</td>
<td>0.28 (0.66)</td>
<td>.001</td>
<td>NA</td>
<td>NA</td>
<td/>
</tr>
<tr>
<td>SCI-SET</td>
<td align="center">—</td>
<td align="center">—</td>
<td/>
<td>0.36 (0.32)</td>
<td>0.04 (0.42)</td>
<td>.02</td>
<td>0.44 (0.57)</td>
<td>0.13 (0.35)</td>
<td>.04</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1545968312471901">
<p>Abbreviations: rTMS, repetitive transcranial magnetic stimulation; LEMS, lower-extremity motor score; TUG, timed up and go; WISCI-II, walking index for SCI; SCI, spinal cord injury; MAS, Modified Ashworth Scale; SCI-SET, spasticity evaluation tool; NA, not available.</p>
</fn>
<fn id="table-fn4-1545968312471901">
<label>a</label>
<p>Change scores were expressed as mean (standard deviation) for each group. <italic>P</italic> value: comparison is between active versus sham rTMS groups.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-1545968312471901">
<title>Within-Group Comparisons</title>
<sec id="section12-1545968312471901">
<title>Primary outcome measurements</title>
<p>Total lower-extremity muscle strength (ie, LEMS) improved significantly (<xref ref-type="table" rid="table3-1545968312471901">Table 3</xref>, <xref ref-type="fig" rid="fig2-1545968312471901">Figure 2</xref>) after the last session in the active rTMS group (Wilcoxon <italic>t, P</italic> = .005) but not in the sham group (Wilcoxon <italic>t, P</italic> = .25).In the 3 patients who received both stimulations, LEMS improved 18.6% with active rTMS and 3% with sham rTMS.</p>
<table-wrap id="table3-1545968312471901" position="float">
<label>Table 3.</label>
<caption>
<p>Primary and Secondary Outcome Measurements.<sup><xref ref-type="table-fn" rid="table-fn6-1545968312471901">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table3-1545968312471901" xlink:href="10.1177_1545968312471901-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">rTMS</th>
<th align="center">Baseline</th>
<th align="center">First Session</th>
<th align="center">Last Session</th>
<th align="center">Follow-up</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="6">Primary outcome measures</td>
</tr>
<tr>
<td> LEMS</td>
<td>Active</td>
<td>28.4 (6.8)</td>
<td>NA</td>
<td>33.2 (8.8)<sup><xref ref-type="table-fn" rid="table-fn7-1545968312471901">b</xref></sup></td>
<td>NA</td>
</tr>
<tr>
<td/>
<td>Sham</td>
<td>29.6 (4.8)</td>
<td>NA</td>
<td>30.9 (7.0)</td>
<td/>
</tr>
<tr>
<td> Walking speed</td>
<td>Active</td>
<td>0.24 (0.32)</td>
<td>NA</td>
<td>0.40 (0.44)<sup><xref ref-type="table-fn" rid="table-fn7-1545968312471901">b</xref></sup></td>
<td>0.48 (0.53)<sup><xref ref-type="table-fn" rid="table-fn7-1545968312471901">b</xref></sup></td>
</tr>
<tr>
<td/>
<td>Sham</td>
<td>0.26 (0.20)</td>
<td>NA</td>
<td>0.34 (0.26)</td>
<td>0.39 (0.31)</td>
</tr>
<tr>
<td> TUG</td>
<td>Active</td>
<td>84.6 (76.19</td>
<td>NA</td>
<td>62.1 (57.9)</td>
<td>54.11 (46.0)</td>
</tr>
<tr>
<td/>
<td>Sham</td>
<td>74.0(55.84)</td>
<td>NA</td>
<td>49.0 (40.1)</td>
<td>43.4 (41.1)</td>
</tr>
<tr>
<td> WISCI-II</td>
<td>Active</td>
<td>9.50 (5.7)</td>
<td>NA</td>
<td>11.1 (4.4)</td>
<td>11.0 (4.4)</td>
</tr>
<tr>
<td/>
<td>Sham</td>
<td>10.6 (5.2)</td>
<td>NA</td>
<td>12.1 (4.6)</td>
<td>13.1 (4.3)</td>
</tr>
<tr>
<td colspan="6">Secondary outcome measures</td>
</tr>
<tr>
<td> MAS</td>
<td>Active</td>
<td>2.30 (0.8)</td>
<td>1.62 (0.77)<sup><xref ref-type="table-fn" rid="table-fn7-1545968312471901">b</xref></sup></td>
<td>1.60 (0.9)<sup><xref ref-type="table-fn" rid="table-fn7-1545968312471901">b</xref></sup></td>
<td>NA</td>
</tr>
<tr>
<td/>
<td>Sham</td>
<td>1.30 (0.7)</td>
<td>1.58 (0.76)</td>
<td>1.78 (0.7)</td>
<td>NA</td>
</tr>
<tr>
<td> SCI-SET</td>
<td>Active</td>
<td>−067 (0.4)</td>
<td>NA</td>
<td>−0.31 (0.5)</td>
<td>−0.23 (0.5)</td>
</tr>
<tr>
<td/>
<td>Sham</td>
<td>−0.47 (0.9)</td>
<td>NA</td>
<td>−0.43 (0.8)</td>
<td>−0.34 (0.7)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-1545968312471901">
<p>Abbreviations: LEMS, lower-extremity motor score; TUG, timed up and go; WISCI-II, walking index for SCI; SCI, spinal cord injury; MAS, Modified Ashworth Scale; SCI-SET, spasticity evaluation tool; rTMS, repetitive transcranial magnetic stimulation; NA, not available.</p>
</fn>
<fn id="table-fn6-1545968312471901">
<label>a</label>
<p>The data show mean (standard deviation, Wilcoxon test) of LEMS, walking speed, TUG test, WISCI-II, MAS, and SCI-SET at baseline, after first and last sessions of rTMS, and during follow-up.</p>
</fn>
<fn id="table-fn7-1545968312471901">
<label>b</label>
<p><italic>P</italic> &lt; .01 in comparison to baseline.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In patients who received active rTMS, walking speed showed significant improvement after the last session, and the effect was maintained during follow-up (<italic>P</italic> &lt; .01 for all comparisons; <xref ref-type="table" rid="table3-1545968312471901">Table 3</xref>, <xref ref-type="fig" rid="fig3-1545968312471901">Figure 3</xref>). No significant changes were observed in the TUG and WISCI-II (<xref ref-type="table" rid="table3-1545968312471901">Table 3</xref>, <xref ref-type="fig" rid="fig3-1545968312471901">Figure 3</xref>).</p>
<fig id="fig3-1545968312471901" position="float">
<label>Figure 3.</label>
<caption>
<p>Gait scales at baseline, after the last rTMS session and during follow-up period (2 weeks after the last session). Abbreviations: TUG, timed up and go; WISCI-II, walking index for SCI; SCI, spinal cord injury; rTMS, repetitive transcranial magnetic stimulation.</p>
</caption>
<graphic xlink:href="10.1177_1545968312471901-fig3.tif"/></fig>
</sec>
<sec id="section13-1545968312471901">
<title>Secondary outcome measurements</title>
<p>There was significant reduction of spasticity according to MAS after the first and last sessions in the active rTMS group (Wilcoxon <italic>t, P</italic> = .0001 for both comparisons; <xref ref-type="table" rid="table3-1545968312471901">Table 3</xref>) but not in the sham rTMS group. SCI-SET did not change significantly after the last session or during the follow-up period in both groups (<xref ref-type="table" rid="table3-1545968312471901">Table 3</xref>).</p>
</sec>
</sec>
<sec id="section14-1545968312471901">
<title>Correlation Analysis</title>
<p>The change scores of LEMS were significantly correlated with the change scores of walking speed in the active rTMS group (ρ = 0.708; <italic>P</italic> = .02) but not in the sham rTMS group (<italic>P</italic> = .06). There was no correlation between absolute value of gait scales and MAS and SCI-SET. The change scores of gait scales were not correlated with the change scores of SCI-SET at any time of evaluation in both groups (Spearman ρ, <italic>P</italic> &gt; .1 for each comparison).</p>
</sec>
</sec>
<sec id="section15-1545968312471901" sec-type="discussion">
<title>Discussion</title>
<p>The main findings of our study are a significant improvement in LEMS, walking speed, and spasticity after high-frequency rTMS in motor-incomplete SCI patients. The main effects of 15 daily sessions of stimulation on LEMS and walking speed were found in the active rTMS group after the treatment, and it lasted for at least 2 weeks during the follow-up period. In contrast, patients receiving sham stimulation did not show any improvement in clinical and functional assessment after treatment or during follow-up.</p>
<p>Our results demonstrate that high-frequency rTMS combined with rehabilitation therapy can be more effective in the management of motor impairment and spasticity in lower limbs following incomplete SCI than rehabilitation therapy coupled with placebo. In the literature, Belci et al<sup><xref ref-type="bibr" rid="bibr10-1545968312471901">10</xref></sup> reported improvement in general motor score (upper and lower extremities) and in upper-extremity function in 4 patients with incomplete chronic cervical SCI after applying high-frequency rTMS over the vertex for 5 days. High-frequency rTMS at subthreshold intensity can lead to an increase in regional glucose metabolism immediately after the end of the stimulation, suggesting the possibility of an rTMS-induced increase in overall neuronal activity in the stimulated motor area (M1).<sup><xref ref-type="bibr" rid="bibr23-1545968312471901">23</xref></sup> The magnitude and duration of the after effects seem to depend on the intensity and the total number of stimuli, with longer periods of rTMS inducing a more consistent and persistent change in corticospinal excitability.<sup><xref ref-type="bibr" rid="bibr11-1545968312471901">11</xref>,<xref ref-type="bibr" rid="bibr21-1545968312471901">21</xref>,<xref ref-type="bibr" rid="bibr22-1545968312471901">22</xref></sup> The facilitation of corticospinal excitability induced by high-frequency rTMS could be long lasting.<sup><xref ref-type="bibr" rid="bibr20-1545968312471901">20</xref>,<xref ref-type="bibr" rid="bibr24-1545968312471901">24</xref>,<xref ref-type="bibr" rid="bibr25-1545968312471901">25</xref></sup> According to the other study, rTMS also could reduce corticospinal inhibition, which consequently could induce motor improvement in SCI.<sup><xref ref-type="bibr" rid="bibr10-1545968312471901">10</xref></sup> It is possible that motor score improvement and amelioration of spasticity with rTMS in SCI can be induced through enhancement of descending corticospinal projections and/or reduction in corticospinal inhibition.<sup><xref ref-type="bibr" rid="bibr20-1545968312471901">20</xref></sup> Enhancement of descending corticospinal projections may induce amelioration of spasticity through some effect on propriospinal interneurons, as has been hypothesized before.<sup><xref ref-type="bibr" rid="bibr20-1545968312471901">20</xref>,<xref ref-type="bibr" rid="bibr24-1545968312471901">24</xref></sup> Further studies are needed to understand the effect of rTMS on the improvement of spasticity.</p>
<p>Our results showed also that there was improvement in walking speed in the active rTMS group, which was correlated with the improvement in LEMS. Supraspinal centers are activated during locomotion, especially to provide equilibrium and visuomotor control and to coordinate leg responses.<sup><xref ref-type="bibr" rid="bibr26-1545968312471901">26</xref></sup> In patients with SCI, MEP amplitudes in the TA seem to allow for prediction of recovery of function mediated by the corticospinal tracts.<sup><xref ref-type="bibr" rid="bibr5-1545968312471901">5</xref>,<xref ref-type="bibr" rid="bibr6-1545968312471901">6</xref></sup> Furthermore, walking function is highly related to MEP recovery in the TA in these patients.<sup><xref ref-type="bibr" rid="bibr5-1545968312471901">5</xref></sup> It is striking that the length of time since injury onset in SCI may have affected the efficacy of synaptic plasticity within the spinal cord, within supraspinal centers, or between those centers.<sup><xref ref-type="bibr" rid="bibr26-1545968312471901">26</xref>,<xref ref-type="bibr" rid="bibr27-1545968312471901">27</xref></sup> It is possible that some improvement in gait function can be induced through the facilitation of corticospinal excitability,<sup><xref ref-type="bibr" rid="bibr20-1545968312471901">20</xref>,<xref ref-type="bibr" rid="bibr24-1545968312471901">24</xref>,<xref ref-type="bibr" rid="bibr25-1545968312471901">25</xref></sup> with reduction in corticospinal inhibition<sup><xref ref-type="bibr" rid="bibr10-1545968312471901">10</xref></sup> and with motor score improvement in the lower limbs. In this study, LEMS with active rTMS improved 4.8 out of 50 in 3 weeks, which was correlated with walking speed. This did not occur with sham rTMS, in which LEMS improvement was 1.3 out of 50. Prior studies had shown that the higher the LEMS, the more likely a patient was to recover the ability to walk without physical assistance.<sup><xref ref-type="bibr" rid="bibr28-1545968312471901">28</xref>,<xref ref-type="bibr" rid="bibr29-1545968312471901">29</xref></sup> Greater motor control for walking in terms of walking speed and strength was found as the LEMS approached and exceeded 40 of a possible 50 points.<sup><xref ref-type="bibr" rid="bibr30-1545968312471901">30</xref></sup> In this study, the mean time since SCI was 4.5 weeks, and reevaluation was done in 12 weeks.<sup><xref ref-type="bibr" rid="bibr30-1545968312471901">30</xref></sup> However, in our patients, the mean time since SCI was 6.8 months, and reevaluation was done in 3 weeks.</p>
<p>Timing of stimulation during performance of a psychological task is crucial to producing a TMS-related effect.<sup><xref ref-type="bibr" rid="bibr31-1545968312471901">31</xref>,<xref ref-type="bibr" rid="bibr32-1545968312471901">32</xref></sup> Production of facilitatory effects appears to be time dependent. In studies reporting facilitation, TMS is often applied immediately before a block of trials<sup><xref ref-type="bibr" rid="bibr31-1545968312471901">31</xref></sup> or, within each trial, immediately before a response is to be made.<sup><xref ref-type="bibr" rid="bibr32-1545968312471901">32</xref></sup> In our patients, rTMS was applied less than 30 minutes before onset of training therapy.</p>
<p>Improvement in LEMS and some gait parameters with rTMS was maintained during the follow-up period. Previous studies have demonstrated that cumulative plastic changes can be produced by rTMS in healthy participants<sup><xref ref-type="bibr" rid="bibr33-1545968312471901">33</xref></sup> as well as in those with SCI,<sup><xref ref-type="bibr" rid="bibr20-1545968312471901">20</xref></sup> multiple sclerosis,<sup><xref ref-type="bibr" rid="bibr24-1545968312471901">24</xref></sup> and stroke.<sup><xref ref-type="bibr" rid="bibr25-1545968312471901">25</xref></sup> Another mechanism might be that repeated episodes of long-term potentiation (LTP) lead to remodeling with an increase in active synapses.<sup><xref ref-type="bibr" rid="bibr34-1545968312471901">34</xref>,<xref ref-type="bibr" rid="bibr35-1545968312471901">35</xref></sup> LTP is a long-lasting enhancement in signal transmission between 2 neurons that results from stimulating them synchronously.<sup><xref ref-type="bibr" rid="bibr36-1545968312471901">36</xref></sup> One of several phenomena underlying synaptic plasticity is the ability of chemical synapses to change in strength. LTP is widely considered to be one of the major cellular mechanisms that underlie learning and memory.<sup><xref ref-type="bibr" rid="bibr36-1545968312471901">36</xref></sup></p>
<p>The limitations of our study are as follows: (1) the stimulation intensity applied during active rTMS was relatively low for leg muscles (90% RMT in the lowest muscle threshold of the upper extremity because of absent MEP in the lower extremity in most patients or very high RMT in the 3 other patients); (2) the time lapse since SCI was less than 12 months, which limits the possibility of spontaneous or training-induced recovery to that time; however, according to the literature, greater gains in gait function in SCI occur when training is begun earlier (&lt;6 months postinjury),<sup><xref ref-type="bibr" rid="bibr37-1545968312471901">37</xref></sup> and in this study, only 2 patients from the active rTMS had less than 6 months of evolution, in contrast to 5 patients from the sham group; (3) our patients had variable causes of SCI, and it is unknown whether or not the natural progression of improvement in the first 6 months differs based on SCI etiology; (4) another possible weakness of our study is that improvement in gait parameters may occur when the participant becomes familiar with a given test; to rule out learning the test, inclusion of multiple baseline tests would have been preferable; and (5) MAS used for spasticity evaluation has poor reliability in SCI.<sup><xref ref-type="bibr" rid="bibr15-1545968312471901">15</xref></sup></p>
<p>In conclusion, our results indicate that rTMS combined with gait training is beneficial for motor recovery in the lower limbs, walking speed, and reduction of spasticity in SCI patients. Based on the small effect size for the LEMS and walking speed, a larger trial may need approximately 75 to 100 subjects in each arm to determine efficacy with a moderate effect size for the experimental intervention. At a more conceptual level, our findings show potential advantages of combining rehabilitation strategies with noninvasive brain stimulation techniques to optimize outcome. These beneficial effects were achieved with minimal side effects and with good tolerability. Challenges that remain include exploring the optimal dose and timing of stimulation, developing better strategies for rehabilitation therapy, determining the most responsive characteristics of SCI patients, and examining how to extend the duration of motor and functional improvement to the long term in a larger sample population after SCI.</p>
</sec>
</body>
<back>
<ack>
<p>The authors express their gratitude to Ellen Quirbach, Hochzirl, Austria, for providing editorial help with the manuscript, and Markus Kofler, Hochzirl, Austria, for his constructive comments on the manuscript.</p>
</ack>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by grants from the FIS (PI10/00442) and (PI082004); the Foundation La Marató TV3 (071931), (110930), (110931); and the Cátedra BBVA (CAT06/023).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1545968312471901">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barthélemy</surname><given-names>D</given-names></name>
<name><surname>Grey</surname><given-names>JM</given-names></name>
<name><surname>Nielsen</surname><given-names>JB</given-names></name>
<name><surname>Bouyer</surname><given-names>L</given-names></name>
</person-group>. <article-title>Involvement of the corticospinal tract in the control of human gait</article-title>. <source>Prog Brain Res</source>. <year>2011</year>;<volume>192</volume>:<fpage>181</fpage>-<lpage>197</lpage>.</citation>
</ref>
<ref id="bibr2-1545968312471901">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Winchester</surname><given-names>P</given-names></name>
<name><surname>McColl</surname><given-names>R</given-names></name>
<name><surname>Querry</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>Changes in supraspinal activation patterns following robotic locomotor therapy in motor-incomplete spinal cord injury</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2005</year>;<volume>19</volume>:<fpage>313</fpage>-<lpage>324</lpage>.</citation>
</ref>
<ref id="bibr3-1545968312471901">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Winchester</surname><given-names>P</given-names></name>
<name><surname>Foreman</surname><given-names>N</given-names></name>
<name><surname>Querry</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>Over ground locomotor function in spinal cord injury following body weight supported treadmill training</article-title>. <source>JSCM</source>. <year>2005</year>;<volume>28</volume>:<fpage>139</fpage>.</citation>
</ref>
<ref id="bibr4-1545968312471901">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hicks</surname><given-names>AL</given-names></name>
<name><surname>Adams</surname><given-names>MM</given-names></name>
<name><surname>Martin Finis</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Long-term body weight supported treadmill training and subsequent follow- up in persons with chronic SCI: effects on functional walking ability and measures of subjective wellbeing</article-title>. <source>Spinal Cord</source>. <year>2005</year>;<volume>43</volume>:<fpage>291</fpage>-<lpage>298</lpage>.</citation>
</ref>
<ref id="bibr5-1545968312471901">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petersen</surname><given-names>JA</given-names></name>
<name><surname>Spiess</surname><given-names>M</given-names></name>
<name><surname>Curt</surname><given-names>A</given-names></name>
<name><surname>Dietz</surname><given-names>V</given-names></name>
<name><surname>Schubert</surname><given-names>M</given-names></name>
</person-group>; <collab>Study Group ES</collab>. <article-title>Spinal cord injury: one-year evolution of motor-evoked potentials and recovery of leg motor function in 255 patients</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2012</year>;<volume>26</volume>:<fpage>939</fpage>-<lpage>948</lpage>.</citation>
</ref>
<ref id="bibr6-1545968312471901">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>SL</given-names></name>
<name><surname>Gorassini</surname><given-names>MA</given-names></name>
</person-group>. <article-title>Increases in corticospinal tract function by treadmill training after incomplete spinal cord injury</article-title>. <source>J Neurophysiol</source>. <year>2005</year>;<volume>94</volume>:<fpage>2844</fpage>-<lpage>2855</lpage>.</citation>
</ref>
<ref id="bibr7-1545968312471901">
<label>7.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Lance</surname><given-names>JW</given-names></name>
</person-group>. <article-title>Spasticity: disordered motor control (Year Book)</article-title>. In: <person-group person-group-type="editor">
<name><surname>Feldman</surname><given-names>R</given-names></name>
<name><surname>Young</surname><given-names>R</given-names></name>
<name><surname>Koella</surname><given-names>W</given-names></name>
</person-group>, eds. <source>Symposium Synopsis</source>. <publisher-loc>Chicago, IL</publisher-loc>: <publisher-name>Medical Publishers</publisher-name>; <volume>1980</volume>:<fpage>485</fpage>-<lpage>500</lpage>.</citation>
</ref>
<ref id="bibr8-1545968312471901">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Skold</surname><given-names>C</given-names></name>
<name><surname>Levi</surname><given-names>R</given-names></name>
<name><surname>Seiger</surname><given-names>A</given-names></name>
</person-group>. <article-title>Spasticity after traumatic spinal cord injury: nature, severity, and location</article-title>. <source>Arch Phys Med Rehabil</source>. <year>1999</year>;<volume>80</volume>:<fpage>1548</fpage>-<lpage>1557</lpage>.</citation>
</ref>
<ref id="bibr9-1545968312471901">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bowden</surname><given-names>M</given-names></name>
<name><surname>Stokic</surname><given-names>DS</given-names></name>
</person-group>. <article-title>Clinical and neurophysiologic assessment of strength and spasticity during intrathecal baclofen titration in incomplete spinal cord injury: single-subject design</article-title>. <source>J Spinal Cord Med</source>. <year>2009</year>;<volume>32</volume>:<fpage>183</fpage>-<lpage>190</lpage>.</citation>
</ref>
<ref id="bibr10-1545968312471901">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Belci</surname><given-names>M</given-names></name>
<name><surname>Catley</surname><given-names>M</given-names></name>
<name><surname>Husain</surname><given-names>M</given-names></name>
<name><surname>Frankel</surname><given-names>HL</given-names></name>
<name><surname>Davey</surname><given-names>NJ</given-names></name>
</person-group>. <article-title>Magnetic brain stimulation can improve clinical outcome in incomplete spinal cord injured patients</article-title>. <source>Spinal Cord</source>. <year>2004</year>;<volume>42</volume>:<fpage>417</fpage>-<lpage>419</lpage>.</citation>
</ref>
<ref id="bibr11-1545968312471901">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hiscock</surname><given-names>A</given-names></name>
<name><surname>Miller</surname><given-names>S</given-names></name>
<name><surname>Rothwell</surname><given-names>J</given-names></name>
<name><surname>Tallis</surname><given-names>RC</given-names></name>
<name><surname>Pomeroy</surname><given-names>VM</given-names></name>
</person-group>. <article-title>Informing dose-finding studies of repetitive transcranial magnetic stimulation to enhance motor function: a qualitative systematic review</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2008</year>;<volume>22</volume>:<fpage>228</fpage>-<lpage>249</lpage>.</citation>
</ref>
<ref id="bibr12-1545968312471901">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuppuswamy</surname><given-names>A</given-names></name>
<name><surname>Balasubramaniam</surname><given-names>AV</given-names></name>
<name><surname>Maksimovic</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>Action of 5Hz repetitive transcranial magnetic stimulation on sensory, motor and autonomic function in human spinal cord injury</article-title>. <source>Clin Neurophysiol</source>. <year>2011</year>;<volume>122</volume>:<fpage>2452</fpage>-<lpage>2461</lpage>.</citation>
</ref>
<ref id="bibr13-1545968312471901">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marino</surname><given-names>RJ</given-names></name>
<name><surname>Barros</surname><given-names>T</given-names></name>
<name><surname>Biering-Sorensen</surname><given-names>F</given-names></name>
<etal/></person-group>; <collab>ASIA Neurological Standards Committee 2002</collab>. <article-title>International standards for neurological classification of spinal cord injury</article-title>. <source>J Spinal Cord Med</source>. <year>2003</year>;<volume>26</volume>(<supplement>suppl</supplement>):<fpage>S50</fpage>-<lpage>S56</lpage>.</citation>
</ref>
<ref id="bibr14-1545968312471901">
<label>14.</label>
<citation citation-type="book">
<collab>Association ASI</collab>. <source>International Standards for Neurological Classification of Spinal Cord Injury, Revised 2002</source>; <publisher-loc>Chicago, IL</publisher-loc>. <publisher-name>American Spinal Injury Association</publisher-name>; <year>2002</year>.</citation>
</ref>
<ref id="bibr15-1545968312471901">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rossier</surname><given-names>P</given-names></name>
<name><surname>Wade</surname><given-names>DT</given-names></name>
</person-group>. <article-title>Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2001</year>;<volume>82</volume>:<fpage>9</fpage>-<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr16-1545968312471901">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Hedel</surname><given-names>HJ</given-names></name>
<name><surname>Wirz</surname><given-names>M</given-names></name>
<name><surname>Dietz</surname><given-names>V</given-names></name>
</person-group>. <article-title>Standardized assessment of walking capacity after spinal cord injury: the European network approach</article-title>. <source>Neurol Res</source>. <year>2008</year>;<volume>30</volume>:<fpage>61</fpage>-<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr17-1545968312471901">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ditunno</surname><given-names>JF</given-names><suffix>Jr</suffix></name>
<name><surname>Barbeau</surname><given-names>H</given-names></name>
<name><surname>Dobkin</surname><given-names>BH</given-names></name>
<etal/></person-group>. <article-title>Validity of the walking scale for spinal cord injury and other domains of function in a multicenter clinical trial</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2007</year>;<volume>21</volume>:<fpage>539</fpage>-<lpage>550</lpage>.</citation>
</ref>
<ref id="bibr18-1545968312471901">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Craven</surname><given-names>BC</given-names></name>
<name><surname>Morris</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Modified Ashworth Scale reliability for measurement of lower extremity spasticity among patients with SCI</article-title>. <source>Spinal Cord</source>. <year>2010</year>;<volume>48</volume>:<fpage>207</fpage>-<lpage>213</lpage>.</citation>
</ref>
<ref id="bibr19-1545968312471901">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adams</surname><given-names>MM</given-names></name>
<name><surname>Ginis</surname><given-names>KA</given-names></name>
<name><surname>Hicks</surname><given-names>AL</given-names></name>
</person-group>. <article-title>The spinal cord injury spasticity evaluation tool: development and evaluation</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2007</year>;<volume>88</volume>:<fpage>1185</fpage>-<lpage>1192</lpage>.</citation>
</ref>
<ref id="bibr20-1545968312471901">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kumru</surname><given-names>H</given-names></name>
<name><surname>Murillo</surname><given-names>N</given-names></name>
<name><surname>Samso</surname><given-names>JV</given-names></name>
<etal/></person-group>. <article-title>Reduction of spasticity with repetitive transcranial magnetic stimulation in patients with spinal cord injury</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2010</year>;<volume>24</volume>:<fpage>435</fpage>-<lpage>441</lpage>.</citation>
</ref>
<ref id="bibr21-1545968312471901">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pascual-Leone</surname><given-names>A</given-names></name>
<name><surname>Valls-Solé</surname><given-names>J</given-names></name>
<name><surname>Wassermann</surname><given-names>EM</given-names></name>
<name><surname>Hallett</surname><given-names>M</given-names></name>
</person-group>. <article-title>Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex</article-title>. <source>Brain</source>. <year>1994</year>;<volume>117</volume>:<fpage>847</fpage>-<lpage>858</lpage>.</citation>
</ref>
<ref id="bibr22-1545968312471901">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maeda</surname><given-names>F</given-names></name>
<name><surname>Keenan</surname><given-names>JP</given-names></name>
<name><surname>Tormos</surname><given-names>JM</given-names></name>
<name><surname>Topka</surname><given-names>H</given-names></name>
<name><surname>Pascual-Leone</surname><given-names>A</given-names></name>
</person-group>. <article-title>Interindividual variability of the modulatory effects of repetitive transcranial magnetic stimulation on cortical excitability</article-title>. <source>Exp Brain Res</source>. <year>2000</year>;<volume>133</volume>:<fpage>425</fpage>-<lpage>430</lpage>.</citation>
</ref>
<ref id="bibr23-1545968312471901">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Siebner</surname><given-names>HR</given-names></name>
<name><surname>Peller</surname><given-names>M</given-names></name>
<name><surname>Willoch</surname><given-names>F</given-names></name>
<etal/></person-group>. <article-title>Lasting cortical activation after repetitive TMS of the motor cortex: a glucose metabolic study</article-title>. <source>Neurology</source>. <year>2000</year>;<volume>54</volume>:<fpage>956</fpage>-<lpage>963</lpage>.</citation>
</ref>
<ref id="bibr24-1545968312471901">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Centonze</surname><given-names>D</given-names></name>
<name><surname>Koch</surname><given-names>G</given-names></name>
<name><surname>Versace</surname><given-names>V</given-names></name>
<etal/></person-group>. <article-title>Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis</article-title>. <source>Neurology</source>. <year>2007</year>;<volume>68</volume>:<fpage>1045</fpage>-<lpage>1050</lpage>.</citation>
</ref>
<ref id="bibr25-1545968312471901">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>RY</given-names></name>
<name><surname>Tseng</surname><given-names>HY</given-names></name>
<name><surname>Liao</surname><given-names>KK</given-names></name>
<name><surname>Wang</surname><given-names>CJ</given-names></name>
<name><surname>Lai</surname><given-names>KL</given-names></name>
<name><surname>Yang</surname><given-names>YR</given-names></name>
</person-group>. <article-title>rTMS combined with task-oriented training to improve symmetry of interhemishperic corticomotor excitability and gait performance after stroke: a randomized trial</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2012</year>;<volume>26</volume>:<fpage>222</fpage>-<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr26-1545968312471901">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dobkin</surname><given-names>BH</given-names></name>
</person-group>. <article-title>Spinal and supraspinal plasticity after incomplete spinal cord injury: correlations between functional magnetic resonance imaging and engaged locomotor networks</article-title>. <source>Prog Brain Res</source>. <year>2000</year>;<volume>128</volume>:<fpage>99</fpage>-<lpage>111</lpage>.</citation>
</ref>
<ref id="bibr27-1545968312471901">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Finnerty</surname><given-names>G</given-names></name>
<name><surname>Roberts</surname><given-names>L</given-names></name>
<name><surname>Connors</surname><given-names>B</given-names></name>
</person-group>. <article-title>Sensory experience modifies the short-term dynamics of neocortical synapses</article-title>. <source>Nature</source>. <year>1999</year>;<volume>400</volume>:<fpage>367</fpage>-<lpage>371</lpage>.</citation>
</ref>
<ref id="bibr28-1545968312471901">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waters</surname><given-names>R</given-names></name>
<name><surname>Adkins</surname><given-names>R</given-names></name>
<name><surname>Yakura</surname><given-names>J</given-names></name>
<etal/></person-group>. <article-title>Prediction of ambulatory performance based on motor scores derived from standards of the American Spinal Injury Association</article-title>. <source>Arch Phys Med Rehabil</source>. <year>1994</year>;<volume>75</volume>:<fpage>756</fpage>-<lpage>760</lpage>.</citation>
</ref>
<ref id="bibr29-1545968312471901">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kirshblum</surname><given-names>SC</given-names></name>
<name><surname>O’Connor</surname><given-names>KC</given-names></name>
</person-group>. <article-title>Predicting neurologic recovery in traumatic cervical spinal cord injury</article-title>. <source>Arch Phys Med Rehabil</source>. <year>1998</year>;<volume>79</volume>:<fpage>1456</fpage>-<lpage>1466</lpage>.</citation>
</ref>
<ref id="bibr30-1545968312471901">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dobkin</surname><given-names>B</given-names></name>
<name><surname>Barbeau</surname><given-names>H</given-names></name>
<name><surname>Deforge</surname><given-names>D</given-names></name>
<etal/></person-group>. <article-title>The evolution of walking-related outcomes over the first 12 weeks of rehabilitation for incomplete traumatic spinal cord injury: the multicenter randomized Spinal Cord Injury Locomotor Trial</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2007</year>;<volume>21</volume>:<fpage>25</fpage>-<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr31-1545968312471901">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sparing</surname><given-names>R</given-names></name>
<name><surname>Mottaghy</surname><given-names>FM</given-names></name>
<name><surname>Hungs</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Repetitive transcranial magnetic stimulation effects on language function depend on the stimulation parameters</article-title>. <source>J Clin Neurophysiol</source>. <year>2001</year>;<volume>18</volume>:<fpage>326</fpage>-<lpage>330</lpage>.</citation>
</ref>
<ref id="bibr32-1545968312471901">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grosbras</surname><given-names>MH</given-names></name>
<name><surname>Paus</surname><given-names>T</given-names></name>
</person-group>. <article-title>Transcranial magnetic stimulation of the human frontal eye field facilitates visual awareness</article-title>. <source>Eur J Neurosci</source>. <year>2003</year>;<volume>18</volume>:<fpage>3121</fpage>-<lpage>3126</lpage>.</citation>
</ref>
<ref id="bibr33-1545968312471901">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baumer</surname><given-names>T</given-names></name>
<name><surname>Lange</surname><given-names>R</given-names></name>
<name><surname>Liepert</surname><given-names>J</given-names></name>
<etal/></person-group>. <article-title>Repeated premotor rTMS lead to cumulative changes of motor cortex excitability in humans</article-title>. <source>Neuroimage</source>. <year>2003</year>;<volume>20</volume>:<fpage>550</fpage>-<lpage>560</lpage>.</citation>
</ref>
<ref id="bibr34-1545968312471901">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leuner</surname><given-names>B</given-names></name>
<name><surname>Shors</surname><given-names>TJ</given-names></name>
</person-group>. <article-title>New spines, new memories</article-title>. <source>Mol Neurobiol</source>. <year>2004</year>;<volume>29</volume>:<fpage>117</fpage>-<lpage>130</lpage>.</citation>
</ref>
<ref id="bibr35-1545968312471901">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matsuzaki</surname><given-names>M</given-names></name>
<name><surname>Honkura</surname><given-names>N</given-names></name>
<name><surname>Ellis-Davies</surname><given-names>GCR</given-names></name>
<name><surname>Kasai</surname><given-names>H</given-names></name>
</person-group>. <article-title>Structural basis of long-term potentiation in single dendritic spines</article-title>. <source>Nature</source>. <year>2004</year>;<volume>429</volume>:<fpage>761</fpage>-<lpage>766</lpage>.</citation>
</ref>
<ref id="bibr36-1545968312471901">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cooke</surname><given-names>SF</given-names></name>
<name><surname>Bliss</surname><given-names>TV</given-names></name>
</person-group>. <article-title>Plasticity in the human central nervous system</article-title>. <source>Brain</source>. <year>2006</year>;<volume>129</volume>:<fpage>1659</fpage>-<lpage>1673</lpage>.</citation>
</ref>
<ref id="bibr37-1545968312471901">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Benito-Penalva</surname><given-names>J</given-names></name>
<name><surname>Edwards</surname><given-names>DJ</given-names></name>
<name><surname>Opisso</surname><given-names>E</given-names></name>
<etal/></person-group>. <article-title>Gait training in human spinal cord injury using electromechanical systems: effect of device type and patient characteristics</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2011</year>;<volume>93</volume>:<fpage>404</fpage>-<lpage>412</lpage>.</citation>
</ref>
<ref id="bibr38-1545968312471901">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peinemann</surname><given-names>A</given-names></name>
<name><surname>Reimer</surname><given-names>B</given-names></name>
<name><surname>Loer</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Long-lasting increase in corticospinal excitability after 1800 pulses of subthreshold 5 Hz repetitive TMS to the primary motor cortex</article-title>. <source>Clin Neurophysiol</source>. <year>2004</year>;<volume>115</volume>:<fpage>1519</fpage>-<lpage>1526</lpage>.</citation>
</ref>
<ref id="bibr39-1545968312471901">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nielsen</surname><given-names>JB</given-names></name>
</person-group>. <article-title>How we walk: central control of muscle activity during human walking</article-title>. <source>Neuroscientist</source>. <year>2003</year>;<volume>9</volume>:<fpage>195</fpage>-<lpage>204</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>